A detailed history of Arrowstreet Capital, Limited Partnership transactions in Merck & Co., Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 6,207,199 shares of MRK stock, worth $611 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
6,207,199
Previous 4,747,708 30.74%
Holding current value
$611 Million
Previous $626 Million 22.67%
% of portfolio
0.68%
Previous 0.58%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $181 Million - $194 Million
1,459,491 Added 30.74%
6,207,199 $768 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $94.1 Million - $110 Million
-830,589 Reduced 14.89%
4,747,708 $626 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $392 Million - $427 Million
-3,913,447 Reduced 41.23%
5,578,297 $608 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $273 Million - $303 Million
-2,648,429 Reduced 21.82%
9,491,744 $977 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $149 Million - $163 Million
1,374,519 Added 12.77%
12,140,173 $1.4 Billion
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $173 Million - $193 Million
1,683,252 Added 18.53%
10,765,654 $1.15 Billion
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $68.2 Million - $87.4 Million
-779,907 Reduced 7.91%
9,082,402 $1.01 Billion
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $41.7 Million - $46.8 Million
493,351 Added 5.27%
9,862,309 $849 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $32.7 Million - $37.1 Million
-391,753 Reduced 4.01%
9,368,958 $854 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $106 Million - $119 Million
1,441,584 Added 17.33%
9,760,711 $801 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $127 Million - $159 Million
1,751,969 Added 26.68%
8,319,127 $638 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $84.1 Million - $92.4 Million
1,172,684 Added 21.74%
6,567,158 $493 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $75.3 Million - $83.2 Million
-1,070,264 Reduced 16.56%
5,394,474 $420 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $162 Million - $191 Million
2,355,505 Added 57.32%
6,464,738 $498 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $98 Million - $109 Million
-1,365,954 Reduced 24.95%
4,109,233 $336 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $232 Million - $263 Million
-3,173,166 Reduced 36.69%
5,475,187 $454 Million
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $211 Million - $240 Million
-3,000,696 Reduced 25.76%
8,648,353 $669 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $91.2 Million - $126 Million
1,440,141 Added 14.11%
11,649,049 $896 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $145 Million - $164 Million
1,869,534 Added 22.42%
10,208,908 $929 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $68.4 Million - $74.5 Million
-898,832 Reduced 9.73%
8,339,374 $702 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $114 Million - $133 Million
1,627,549 Added 21.39%
9,238,206 $775 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $105 Million - $120 Million
1,511,692 Added 24.79%
7,610,657 $633 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $165 Million - $191 Million
2,524,177 Added 70.61%
6,098,965 $466 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $9.06 Million - $10.7 Million
157,080 Added 4.6%
3,574,788 $254 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $41.6 Million - $48.9 Million
818,233 Added 31.48%
3,417,708 $207 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $255 Million - $296 Million
-4,995,064 Reduced 65.77%
2,599,475 $142 Million
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $58.2 Million - $69.5 Million
1,127,036 Added 17.43%
7,594,539 $427 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $379 Million - $408 Million
6,467,503
6,467,503 $414 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.